DJIA 17,740.10 109.83 0.62%
NASDAQ 5,101.18 11.97 0.24%
S&P 500 2,104.98 11.73 0.56%
market minute promo

Biogen Idec (NASDAQ: BIIB)

311.77 -8.16 (-2.55%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

BIIB $311.66 -2.59%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $321.92
Previous Close $319.93
Daily Range $313.39 - $323.00
52-Week Range $290.85 - $480.18
Market Cap $73.3B
P/E Ratio 21.60
Dividend (Yield) $0.00 (0.0%)
Volume 1,265,330
Average Daily Volume 2,463,439
Current FY EPS $16.62

Sector

Healthcare

Industry

Drug Makers

Biogen Idec (BIIB) Description

The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies. Website: http://www.biogenidec.com/

News & Commentary Rss Feed

3 Big Biotech Buybacks That Investors Should Love

Big biotech companies are flush with cash and are using it to reward shareholders. Here are three companies that are spending big on share buybacks.

Gilead Q2 Earnings: KAPOW! BAM! BOOM! (Yes, That Good)

The Zacks Analyst Blog Highlights: Biogen, Ligand Pharmaceuticals, bluebird bio, Regeneron Pharmaceu

The Zacks Analyst Blog Highlights: Biogen, Ligand Pharmaceuticals, bluebird bio, Regeneron Pharmaceuticals and Exelixis - Press Releases

Is More M&A On The Way For Large-Cap Biotechs?

ISIS Pharmaceuticals: Another Entry Point

Tuesday 7/28 Insider Buying Report: BIIB, MJN

InsiderInsights.com Daily Round Up 7/27/15: Allegheny Technologies, Fibrocell Science, Mead Johnson

InsiderInsights.com Daily Round Up 7/27/15: Allegheny Technologies, Fibrocell Science, Mead Johnson Nutrition, Mobile Mini

Watching Twitter for Moves at Teva and Biogen

5 Things Biogen's Management Wants You to Know

Tecfidera, more Tecfidera, and how to replace Tecfidera growth.

Cramer -- Twitter Has Short-Term Problems; Gilead's 'Problem' Is Too Much Cash

See More BIIB News...

BIIB's Top Competitors

BIIB $311.77 (-2.55%)
Current stock: BIIB
AMGN $171.77 (-0.56%)
Current stock: AMGN
GILD $116.96 (3.44%)
Current stock: GILD
$0.00 (0.00%)
Current stock: